362 related articles for article (PubMed ID: 12414951)
21. Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1.
Shao E; Zhao S; Dong Y; Wang Y; Fei Y; Li S; Wang L; Bashir T; Luan T; Lin L; Wang Y; Zhao W; Zhong Z
Antiviral Res; 2023 Jul; 215():105621. PubMed ID: 37156267
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.
McCall KD; Thuma JR; Courreges MC; Benencia F; James CB; Malgor R; Kantake N; Mudd W; Denlinger N; Nolan B; Wen L; Schwartz FL
Endocrinology; 2015 Feb; 156(2):453-61. PubMed ID: 25422874
[TBL] [Abstract][Full Text] [Related]
23. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4.
Yap IS; Giddings G; Pocock E; Chantler JK
J Gen Virol; 2003 Nov; 84(Pt 11):3051-3068. PubMed ID: 14573810
[TBL] [Abstract][Full Text] [Related]
24. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
25. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
26. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
[TBL] [Abstract][Full Text] [Related]
27. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.
Horwitz MS; Ilic A; Fine C; Rodriguez E; Sarvetnick N
J Clin Invest; 2002 Jan; 109(1):79-87. PubMed ID: 11781353
[TBL] [Abstract][Full Text] [Related]
28. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
[TBL] [Abstract][Full Text] [Related]
29. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK; Olsson A; Korsgren O; Frisk G
Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
31. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
Wang Y; Pfeiffer JK
mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
[TBL] [Abstract][Full Text] [Related]
32. Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype.
Phillips L; Tapprich WE
J Virol; 2023 May; 97(5):e0044823. PubMed ID: 37074194
[TBL] [Abstract][Full Text] [Related]
33. A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice.
Rasquinha MT; Lasrado N; Sur M; Mone K; Qiu H; Riethoven JJ; Sobel RA; Reddy J
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679922
[TBL] [Abstract][Full Text] [Related]
34. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.
Mena I; Fischer C; Gebhard JR; Perry CM; Harkins S; Whitton JL
Virology; 2000 Jun; 271(2):276-88. PubMed ID: 10860882
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
36. Group B coxsackievirus virulence.
Tracy S; Gauntt C
Curr Top Microbiol Immunol; 2008; 323():49-63. PubMed ID: 18357765
[TBL] [Abstract][Full Text] [Related]
37. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
38. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.
Li SW; Koya V; Li Y; Donelan W; Lin P; Reeves WH; Yang LJ
Lab Invest; 2010 Jan; 90(1):31-9. PubMed ID: 19901909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
